Algunas aprobaciones recientes de la Administración de Alimentos y Medicamentos (Food and Drug Administration, FDA) han hecho que las personas se enteren de que hay tratamientos agnósticos con respecto a los tumores. Pero, ¿qué significa eso y cómo podría beneficiar a alguien con cáncer? El director médico anterior (2013-2021) de la American Society of Clinical Oncology (Sociedad Estadounidense de Oncología Clínica), Richard L. Schilsky, aporta información sobre esta nueva forma de abordar el tratamiento del cáncer.
In this podcast, Drs. Eliza Park and Paula Rauch discuss how a parent with metastatic cancer can talk with their children about their prognosis, including the challenges of having this discussion and ways to navigate the conversation with children of different ages.
Karen Warner Schueler describes what it was like to suddenly become a caregiver after her husband was diagnosed with metastatic cancer and what helped her avoid burnout from the role.
In this “Voices on Cancer” post, oncology nurse Claire Thevenot shares what it was like being diagnosed with metastatic breast cancer and how the diagnosis led her to a full-time career in patient advocacy.
Metastatic breast cancer survivor Marianne McNally describes how genomic testing and creating a game plan with her care team has allowed her to have a sense of control throughout her cancer experience.
How Finding the Right Primary Care Physician During Cancer Has Helped My Physical and Emotional Health
In this post, metastatic breast cancer survivor Martha Carlson shares why searching for the right primary care physician during cancer was so important for her and how this doctor helps her understand and address her overall health.
In this month’s From the Editor’s Desk, Dr. Schapira writes about the challenges of living with metastatic breast cancer.
ASCO Annual Meeting 2019: Laparoscopic Surgery for Metastatic Colorectal Cancer, Expanding Eligibility Criteria for Advanced Non-Small Cell Lung Cancer, and a New Targeted Therapy for Advanced Bladder Cancer
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include minimally invasive surgery for liver metastases in colorectal cancer, expanding clinical trial eligibility criteria for non-small cell lung cancer, and a new targeted therapy for advanced bladder cancer.
The stigma of lung cancer has powerful consequences for those diagnosed with the disease. Dr. Narjust Duma shares the story of a patient who was brave in the face of lung cancer but feared the judgment of her community.